Cargando…

Is Postmastectomy Radiotherapy Really Needed in Breast Cancer Patients with Many Positive Axillary Lymph Nodes?

BACKGROUND: Postmastectomy radiotherapy (PMRT) improves survival by eliminating potential occult lesions in the chest wall and lymphatic drainage area. Meta-analysis has shown that PMRT reduces mortality and local recurrence of patients with node positive breast cancer, but there is no specific data...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marinko, Tanja, Stanic, Karmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137357/ https://www.ncbi.nlm.nih.gov/pubmed/30210045 http://dx.doi.org/10.2478/raon-2018-0012

Ejemplares similares

Effects of postmastectomy radiotherapy on prognosis in different tumor stages of breast cancer patients with positive axillary lymph nodes
por: Jia, Miao-Miao, et al.
Publicado: (2014)

Impact of postmastectomy radiation therapy in T1-2 breast cancer patients with 1-3 positive axillary lymph nodes
por: Yin, Hang, et al.
Publicado: (2017)

Radiotherapy instead of axillary lymph node dissection: evaluation of axillary lymph node dose coverage with whole breast radiotherapy
por: Bukovszky, Bence, et al.
Publicado: (2022)

The effect of postmastectomy radiotherapy in node-positive triple-negative breast cancer
por: Zhang, Lei, et al.
Publicado: (2020)

Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy
por: Wu, San-Gang, et al.
Publicado: (2014)

Real-world impact of postmastectomy radiotherapy in T1–2 breast cancer with one to three positive lymph nodes
por: Li, Feng-Yan, et al.
Publicado: (2020)

Postmastectomy irradiation in breast in breast cancer patients with T1-2 and 1-3 positive axillary lymph nodes: Is there a role for radiation therapy?
por: Cosar, Rusen, et al.
Publicado: (2011)

Which Patients Might Benefit from Postmastectomy Radiotherapy in Breast Cancer Patients with T1-2 Tumor and 1-3 Axillary Lymph Nodes Metastasis?
por: Kong, Moonkyoo, et al.
Publicado: (2013)

A Prognostic Risk Stratification Model to Identify Potential Population Benefiting From Postmastectomy Radiotherapy in T1–2 Breast Cancer With 1–3 Positive Axillary Lymph Nodes
por: Hou, Niuniu, et al.
Publicado: (2021)

Effect of postmastectomy radiotherapy on triple-negative breast cancer with T1-2 and 1-3 positive axillary lymph nodes: a population-based study using the SEER 18 database
por: Zhang, Jie, et al.
Publicado: (2019)

Whether adjuvant radiotherapy is desired for postmastectomy patients with T1–T2 tumors and 1–3 positive axillary lymph nodes who received modern systemic therapy?
por: Lai, Shih-Fan, et al.
Publicado: (2019)

Real-world outcomes of postmastectomy radiotherapy in breast cancer patients with 1–3 positive lymph nodes: a retrospective study
por: Chitapanarux, Imjai, et al.
Publicado: (2014)

The Prognostic Significance of the Lymph Node Ratio in Axillary Lymph Node Positive Breast Cancer
por: Kim, Ji-Yoon, et al.
Publicado: (2011)

Predictors of positive axillary lymph nodes in breast cancer patients with metastatic sentinel lymph node
por: Callejo, IP, et al.
Publicado: (2005)

Dosimetric Comparison of Postmastectomy Radiotherapy Plans for Synchronous Bilateral Breast Cancer, Including Regional Lymph Node Irradiation
por: Wu, Xiuxiu, et al.
Publicado: (2023)

Clinical decision making in postmastectomy radiotherapy in node negative breast cancer
por: Barrientos, Rodrigo, et al.
Publicado: (2018)

How Many Sentinel Lymph Nodes Are Enough for Accurate Axillary Staging in T1-2 Breast Cancer?
por: Ban, Eun Jeong, et al.
Publicado: (2011)

Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial)
por: Garcia-Tejedor, Amparo, et al.
Publicado: (2023)

Number of Negative Lymph Nodes Can Predict Survival after Postmastectomy Radiotherapy According to Different Breast Cancer Subtypes
por: Wu, San-Gang, et al.
Publicado: (2015)

Breast Axillary Lymph Node Metastasis
por: Cavalli, Luciane R., et al.
Publicado: (2011)

Postmastectomy radiation therapy can improve survival for breast cancer patients with 1–3 positive axillary lymph nodes: a retrospective cohort study using the SEER database
por: Yang, Jian, et al.
Publicado: (2021)

Is the sentinel lymph node biopsy more sensitive for the identification of positive lymph nodes in breast cancer than the axillary lymph node dissection?
por: Smeets, Ann, et al.
Publicado: (2013)

Role of postmastectomy radiation therapy in breast cancer patients with T1–2 and 1–3 positive lymph nodes
por: Cihan, Yasemin Benderli, et al.
Publicado: (2016)

Postmastectomy/Axillary Node Dissection Chyloma: The Additional Value of SPECT/CT Lymphoscintigraphy
por: Thang, Sue Ping, et al.
Publicado: (2014)

Positive non-sentinel axillary lymph nodes in breast cancer with 1-2 sentinel lymph node metastases
por: Zheng, Jianwei, et al.
Publicado: (2018)

Trends in the Application of Postmastectomy Radiotherapy for Breast Cancer With 1 to 3 Positive Axillary Nodes and Tumors ≤5 cm in the Modern Treatment Era: A Retrospective Korean Breast Cancer Society Report
por: Chang, Jee Suk, et al.
Publicado: (2016)

Fat-enlarged axillary lymph nodes are associated with node-positive breast cancer in obese patients
por: diFlorio-Alexander, Roberta M., et al.
Publicado: (2021)

Patterns of postmastectomy radiation therapy in clinically node-positive breast cancer patients with pathologically negative lymph nodes after neoadjuvant chemotherapy
por: SAYAN, Mutlay, et al.
Publicado: (2021)

Prognostic value of extranodal extension in axillary lymph node-positive breast cancer
por: Ma, XiaoXi, et al.
Publicado: (2021)

Identification of Risk Factors Associated with Axillary Lymph Node Metastasis for Sentinel Lymph Node-Positive Breast Cancer Patients
por: He, Zhen, et al.
Publicado: (2020)

Histological scoring of immune and stromal features in breast and axillary lymph nodes is prognostic for distant metastasis in lymph node‐positive breast cancers
por: Grigoriadis, Anita, et al.
Publicado: (2018)

Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level
por: Yuan, Qianqian, et al.
Publicado: (2021)

Independent risk factors for axillary lymph node metastasis in breast cancer patients with one or two positive sentinel lymph nodes
por: Zhang, Wei, et al.
Publicado: (2020)

Inconsistent radiotherapy effects between primary tumors and axillary lymph nodes
por: Bi, Zhao, et al.
Publicado: (2022)

A nomogram to predict the probability of axillary lymph node metastasis in early breast cancer patients with positive axillary ultrasound
por: Qiu, Si-Qi, et al.
Publicado: (2016)

Dose to level I and II axillary lymph nodes and lung by tangential field radiation in patients undergoing postmastectomy radiation with tissue expander reconstruction
por: Russo, James K, et al.
Publicado: (2011)

A Nomogram for Identifying HR+/Her2− Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted Axillary Lymph Node Dissection Who Need Abemaciclib Therapy
por: Yang, Hanzhao, et al.
Publicado: (2023)

Quantitative evaluation of metastases in axillary lymph nodes of breast cancer
por: Inokuchi, M, et al.
Publicado: (2003)

Axillary lymph nodes in breast cancer patients: sonographic evaluation
por: Pinheiro, Denise Joffily Pereira da Costa, et al.
Publicado: (2014)

Dissection of Level III Axillary Lymph Nodes in Breast Cancer
por: Hu, Jiejie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7mev1kv4mae4bmhua33rcoo9qi